Crossmark

Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG)

Crossref DOI link: https://doi.org/10.1007/s00198-017-4214-x

Published Online: 2017-09-02

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Celli, M. http://orcid.org/0000-0002-0751-2688
D’Eufemia, P.

Persiani, P.

Turchetti, A.

Febbo, A.

D’Alfonso, Y.

Celli, L.

Zambrano, A.
License Information

Text and Data Mining valid from 2017-09-02
More Information

Article History

Received: 9 June 2017

Accepted: 25 August 2017

First Online: 2 September 2017

Compliance with ethical standards

:

: None.